Literature DB >> 15767800

High specificity of combined TRAP and DBA.44 expression for hairy cell leukemia.

Philip Th Went1, Annette Zimpfer, Ann-Christine Pehrs, Elena Sabattini, Stefano A Pileri, Robert Maurer, Luigi Terracciano, Alexandar Tzankov, Guido Sauter, Stephan Dirnhofer.   

Abstract

Because of marrow fibrosis, bone marrow aspirations are often nonconclusive in patients with hairy cell leukemia (HCL). Therefore, histologic examination is important in HCL but often difficult in cases with low numbers of tumor cells. A combined immunohistochemical positivity for DBA.44 and tartrate-resistant phosphatase was previously found in 100% of HCL and suggested to be specific for this diagnosis. To further assess the diagnostic specificity and sensitivity of this immunohistochemical approach in a higher number of cases, we analyzed 56 HCLs and lymphoma tissue microarrays, including 840 cases of the most frequent non-Hodgkin lymphomas. All HCLs showed combined positivity for these two proteins (100% sensitivity). Both antibodies were often positive in other lymphoma types. DBA.44 reactivity was especially frequent in follicular lymphomas (46%), whereas tartrate-resistant acid phosphatase (TRAP) expression was often seen in mantle cell lymphomas (57%), primary mediastinal large B-cell lymphomas (54%), and chronic lymphocytic leukemia/small lymphocytic lymphoma (41%). A combined DBA.44/TRAP positivity was seen in only 3% of non-HCL non-Hodgkin lymphomas, including cases of diffuse large B-cell lymphomas, follicular lymphomas, chronic lymphatic leukemia/small lymphocytic leukemias, and mantle cell lymphomas. Overall, these data confirm the utility of combined immunohistochemical DBA.44/TRAP expression analysis in confirming the diagnosis of HCL. However, combined positivity for these markers is highly sensitive but not absolutely specific for HCL.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15767800     DOI: 10.1097/01.pas.0000155152.56736.06

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  7 in total

Review 1.  Selective immunophenotyping for diagnosis of B-cell neoplasms: immunohistochemistry and flow cytometry strategies and results.

Authors:  Scott D Boyd; Yasodha Natkunam; John R Allen; Roger A Warnke
Journal:  Appl Immunohistochem Mol Morphol       Date:  2013-03

2.  A comprehensive immunophenotypic marker analysis of hairy cell leukemia in paraffin-embedded bone marrow trephine biopsies--a tissue microarray study.

Authors:  Judit Tóth-Lipták; Klára Piukovics; Zita Borbényi; Judit Demeter; Enikő Bagdi; László Krenács
Journal:  Pathol Oncol Res       Date:  2014-06-06       Impact factor: 3.201

3.  Construction and validation of a bone marrow tissue microarray.

Authors:  Annette Zimpfer; Sharon Schönberg; Alessandro Lugli; Claudio Agostinelli; Stefano A Pileri; Philip Went; Stephan Dirnhofer
Journal:  J Clin Pathol       Date:  2006-05-12       Impact factor: 3.411

Review 4.  Immunohistochemistry in bone marrow pathology: a useful adjunct for morphologic diagnosis.

Authors:  Marcus Kremer; Leticia Quintanilla-Martínez; Jörg Nährig; Christoph von Schilling; Falko Fend
Journal:  Virchows Arch       Date:  2005-10-18       Impact factor: 4.064

5.  Monoclonal antibody HBME-1 reacts with a minor subset of B cells with villous surface and can be useful in the diagnosis of hairy cell leukemia and other indolent lymphoproliferations of villous B lymphocytes.

Authors:  László Krenács; Judit Tóth-Lipták; Judit Demeter; Klára Piukovics; Zita Borbényi; Péter Gogolák; Eszter Sári; Enikő Bagdi
Journal:  Virchows Arch       Date:  2013-10-05       Impact factor: 4.064

6.  Characterization of c-Maf transcription factor in normal and neoplastic hematolymphoid tissue and its relevance in plasma cell neoplasia.

Authors:  Yasodha Natkunam; Sara Tedoldi; Jennifer C Paterson; Shuchun Zhao; Manuel Rodriguez-Justo; Andrew H Beck; Reiner Siebert; David Y Mason; Teresa Marafioti
Journal:  Am J Clin Pathol       Date:  2009-09       Impact factor: 2.493

Review 7.  [Lymphomas and lymphatic leukemias in the bone marrow].

Authors:  P Adam; L Quintanilla-Fend; F Fend
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.